18F fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers

Details for Australian Patent Application No. 2007348145 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Srinivasan, Ananth; Stellfeld, Timo

Agent Davies Collison Cave

Pub. Number AU-A-2007348145

PCT Pub. Number WO2008/104203

Priority 07090079.0 23.04.07 EP; 07090035.2 01.03.07 EP

Filing date 7 September 2007

Wipo publication date 4 September 2008

International Classifications

A61K 49/04 (2006.01) Preparations for testing - X-ray contrast preparations

A61K 31/7072 (2006.01)

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 49/08 (2006.01) Preparations for testing

A61K 49/10 (2006.01) Preparations for testing

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

C07D 249/18 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07K 1/13 (2006.01) General processes for the preparation of peptides

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/023 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/104203 Priority application(s): WO2008/104203

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007348171-Template-fixed peptidomimetics

2007348123-Composition useful for the treatment of type 2 diabetes